US Stock MarketDetailed Quotes

Jade Biosciences (JBIO)

Watchlist
  • 23.355
  • -0.775-3.21%
Close May 15 16:00 ET
  • 23.355
  • 0.0000.00%
Post 20:01 ET
1.15BMarket Cap-12.12P/E (TTM)

Jade Biosciences (JBIO) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q3)Sep 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
523.48%311.3M
384.48%336.16M
--336.16M
126.11%198.91M
--220.94M
--49.93M
--69.39M
--87.97M
-Cash and cash equivalents
10.33%55.09M
27.46%88.44M
--88.44M
-43.04%50.11M
--220.94M
--49.93M
--69.39M
--87.97M
-Short-term investments
--256.21M
--247.72M
--247.72M
--148.8M
----
----
--0
----
Receivables
----
----
----
----
----
----
----
--0
-Related party accounts receivable
----
----
----
----
----
----
----
--0
Other current assets
831.87%7.22M
4,623.13%12.66M
--12.66M
1,026.15%2.46M
--2.04M
--775K
--268K
--218K
Total current assets
528.19%318.52M
400.78%348.82M
--348.82M
128.33%201.36M
--222.98M
--50.7M
--69.65M
--88.19M
Non current assets
Net PPE
10.72%847K
--896K
--896K
--916K
--924K
--765K
--0
----
-Gross PPE
10.72%847K
--896K
--896K
--916K
--924K
--765K
--0
----
Related parties assets
----
----
----
----
----
----
----
--0
Other non current assets
-98.58%69K
-97.81%69K
--69K
-84.99%174K
--60K
--4.86M
--3.15M
--1.16M
Total non current assets
-83.70%916K
-69.32%965K
--965K
-5.95%1.09M
--984K
--5.62M
--3.15M
--1.16M
Total assets
467.13%319.43M
380.48%349.78M
--349.78M
126.59%202.45M
--223.97M
--56.32M
--72.8M
--89.35M
Liabilities
Current liabilities
Payables
-5.60%3.98M
66.74%2.15M
--2.15M
46.26%1.35M
--7.59M
--4.22M
--1.29M
--923K
-accounts payable
-5.60%3.98M
66.74%2.15M
--2.15M
46.26%1.35M
--7.59M
--4.22M
--1.29M
--923K
Current accrued expenses
42.34%12.9M
61.82%11.07M
--11.07M
52.77%12.96M
--8.69M
--9.06M
--6.84M
--8.48M
Other current liabilities
30.61%2.67M
----
----
--4.95M
--3.56M
--2.04M
--1.08M
----
Current liabilities
38.90%22.29M
37.87%16.54M
--16.54M
135.73%22.36M
--21.62M
--16.05M
--12M
--9.48M
Non current liabilities
Long term debt and capital lease obligation
-99.45%679K
-99.33%724K
--724K
-99.23%747K
--792K
--123.78M
--107.6M
--96.7M
-Long term debt
----
----
----
----
----
--123M
--107.6M
--96.7M
-Long term capital lease obligation
-13.28%679K
--724K
--724K
--747K
--792K
--783K
--0
----
Derivative product liabilities
----
----
----
----
----
----
----
--24K
Preferred securities outside stock equity
----
--0
--0
--0
--0
--2K
--2K
--2K
Total non current liabilities
-99.45%679K
-99.33%724K
--724K
-99.23%747K
--792K
--123.79M
--107.6M
--96.73M
Total liabilities
-83.57%22.97M
-85.57%17.26M
--17.26M
-78.25%23.1M
--22.41M
--139.83M
--119.6M
--106.21M
Shareholders'equity
Share capital
600.00%7K
600.00%7K
--7K
400.00%5K
--5K
--1K
--1K
--1K
-common stock
400.00%5K
400.00%5K
--5K
200.00%3K
--3K
--1K
--1K
--1K
-Preferred stock
--2K
--2K
--2K
--2K
--2K
----
--0
----
Retained earnings
-152.22%-214.76M
-271.21%-174.39M
---174.39M
-744.59%-142.46M
---117.28M
---85.15M
---46.98M
---16.87M
Paid-in capital
31,149.48%511.55M
283,012.29%506.77M
--506.77M
10,725,533.33%321.77M
--318.86M
--1.64M
--179K
--3K
Gains losses not affecting retained earnings
---342K
--129K
--129K
--29K
---24K
----
--0
----
Total stockholders'equity
455.00%296.46M
810.52%332.52M
--332.52M
1,163.55%179.35M
--201.56M
---83.51M
---46.8M
---16.86M
Total equity
455.00%296.46M
810.52%332.52M
--332.52M
1,163.55%179.35M
--201.56M
---83.51M
---46.8M
---16.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q3)Sep 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 523.48%311.3M384.48%336.16M--336.16M126.11%198.91M--220.94M--49.93M--69.39M--87.97M
-Cash and cash equivalents 10.33%55.09M27.46%88.44M--88.44M-43.04%50.11M--220.94M--49.93M--69.39M--87.97M
-Short-term investments --256.21M--247.72M--247.72M--148.8M----------0----
Receivables ------------------------------0
-Related party accounts receivable ------------------------------0
Other current assets 831.87%7.22M4,623.13%12.66M--12.66M1,026.15%2.46M--2.04M--775K--268K--218K
Total current assets 528.19%318.52M400.78%348.82M--348.82M128.33%201.36M--222.98M--50.7M--69.65M--88.19M
Non current assets
Net PPE 10.72%847K--896K--896K--916K--924K--765K--0----
-Gross PPE 10.72%847K--896K--896K--916K--924K--765K--0----
Related parties assets ------------------------------0
Other non current assets -98.58%69K-97.81%69K--69K-84.99%174K--60K--4.86M--3.15M--1.16M
Total non current assets -83.70%916K-69.32%965K--965K-5.95%1.09M--984K--5.62M--3.15M--1.16M
Total assets 467.13%319.43M380.48%349.78M--349.78M126.59%202.45M--223.97M--56.32M--72.8M--89.35M
Liabilities
Current liabilities
Payables -5.60%3.98M66.74%2.15M--2.15M46.26%1.35M--7.59M--4.22M--1.29M--923K
-accounts payable -5.60%3.98M66.74%2.15M--2.15M46.26%1.35M--7.59M--4.22M--1.29M--923K
Current accrued expenses 42.34%12.9M61.82%11.07M--11.07M52.77%12.96M--8.69M--9.06M--6.84M--8.48M
Other current liabilities 30.61%2.67M----------4.95M--3.56M--2.04M--1.08M----
Current liabilities 38.90%22.29M37.87%16.54M--16.54M135.73%22.36M--21.62M--16.05M--12M--9.48M
Non current liabilities
Long term debt and capital lease obligation -99.45%679K-99.33%724K--724K-99.23%747K--792K--123.78M--107.6M--96.7M
-Long term debt ----------------------123M--107.6M--96.7M
-Long term capital lease obligation -13.28%679K--724K--724K--747K--792K--783K--0----
Derivative product liabilities ------------------------------24K
Preferred securities outside stock equity ------0--0--0--0--2K--2K--2K
Total non current liabilities -99.45%679K-99.33%724K--724K-99.23%747K--792K--123.79M--107.6M--96.73M
Total liabilities -83.57%22.97M-85.57%17.26M--17.26M-78.25%23.1M--22.41M--139.83M--119.6M--106.21M
Shareholders'equity
Share capital 600.00%7K600.00%7K--7K400.00%5K--5K--1K--1K--1K
-common stock 400.00%5K400.00%5K--5K200.00%3K--3K--1K--1K--1K
-Preferred stock --2K--2K--2K--2K--2K------0----
Retained earnings -152.22%-214.76M-271.21%-174.39M---174.39M-744.59%-142.46M---117.28M---85.15M---46.98M---16.87M
Paid-in capital 31,149.48%511.55M283,012.29%506.77M--506.77M10,725,533.33%321.77M--318.86M--1.64M--179K--3K
Gains losses not affecting retained earnings ---342K--129K--129K--29K---24K------0----
Total stockholders'equity 455.00%296.46M810.52%332.52M--332.52M1,163.55%179.35M--201.56M---83.51M---46.8M---16.86M
Total equity 455.00%296.46M810.52%332.52M--332.52M1,163.55%179.35M--201.56M---83.51M---46.8M---16.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More